Conference to discuss latest advances in brain tumours by non-surgical means, space science

NewsGuard 100/100 Score

The latest advances in the treatment of brain tumours by non-surgical means, space science and non-fossil fuel energy generation, are among the topics being discussed by over 500 international scientists at Queen's University this week.

The physicists, from Europe, the USA, China, Japan, Australia, Canada, Argentina, Brazil and Israel, are attending a week-long conference to discuss the latest developments in atomic and molecular and laser physics.  The 27th International Conference on Photonic, Electronic and Atomic Collisions (ICPEAC) is one of the largest and most prestigious Physics Conferences in the world.

Among the keynote speakers are:

  • Professor Yasunori Yamazaki, a world leader in studies of antimatter at the CERN antiproton facility where cold anti-hydrogen has been successfully formed and trapped. 
  • Dr Walter Meissl (Atomic Physics Laboratory, RIKEN, Japan), an experimental physicist currently working in Japan investigating radiation damage to DNA with importance applications in future Cancer Therapy.
  • Professor Ara Chutjian (NASA Jet Propulsion Laboratory, Pasadena, California), a leading scientist involved in the NASA space science programme. 
  • Dr Chris Calvert, Queen's University Belfast, who is working on a new technique using state of the art ultrafast laser flashes to study bio-molecules such as components of DNA, important for future cancer therapies.

The internationally-acclaimed scientific meeting is taking place in the UK for only the third time since its establishment in New York in 1958.  The selection of Queen's as a venue acknowledges the international profile of the University's School of Mathematics and Physics in atomic physics.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough brain stimulator could revolutionize treatment for neurological disorders